An update on the prevalence and incidence of epilepsy among older adults

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective To estimate the prevalence and incidence of epilepsy among beneficiaries of Arizona Medicare aged 65 and over. Methods An analysis of Medicare administrative claims data for 2009–2011 for the State of Arizona was conducted. Epilepsy was defined as a beneficiary who had either ≥ one claim with diagnostic code of 345.xx (epilepsy) or at least two claims with diagnosis code of 780.3x (seizure) ≥30 days apart. Stroke-related and psychiatric comorbidities were determined by diagnostic codes. Average annual prevalence and incidence were calculated and stratified by demographic characteristics and comorbidities. Odds ratios (OR) and 95% confidence intervals (CI) were calculated as measures of effect for prevalence and incidence and the chi-square statistic was calculated to compare the proportions of epilepsy cases with and without comorbidities (alpha = 0.05). Results The overall average annual prevalence and incidence over the study period was 15.2/1000 and 6.1/1000, respectively. Relative to the 65–69 age group and White beneficiaries, the highest prevalence was observed for beneficiaries 85 years or older (19.8/1000, OR 1.66, 95% CI 1.53–1.81) and Native Americans (21.2/1000, OR 1.42, 95% CI 1.25–1.62). In contrast, the highest incidence rates were observed for beneficiaries 85 years and older (8.5/1000, OR 1.82, 95% CI 1.60–2.07) and for Black beneficiaries (8.7/1000, OR 1.44, 95% CI 1.12–1.86). The incidence rate for Native Americans was not significantly different from that for White beneficiaries (6.2/1000, OR 1.02, 95% CI 0.81–1.29). More than one quarter of all cases (25.7%) and 31% of incident cases had either stroke-related and/or psychiatric comorbidities (all p-values < 0.001). Conclusions Epilepsy is a significant neurological disease among Medicare beneficiaries 65 years and older. Beneficiaries aged 85 and older and Black and Native Americans experienced higher rates of epilepsy than other demographic subgroups compared to White beneficiaries.

Original languageEnglish (US)
Pages (from-to)107-112
Number of pages6
JournalEpilepsy Research
Volume139
DOIs
StatePublished - Jan 1 2018

Fingerprint

Epilepsy
Odds Ratio
Confidence Intervals
North American Indians
Comorbidity
Incidence
Medicare
Psychiatry
Stroke
Demography
Seizures
Cohort Studies
Age Groups

Keywords

  • Comorbidities
  • Epilepsy
  • Incidence
  • Medicare
  • Prevalence

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

An update on the prevalence and incidence of epilepsy among older adults. / Ip, Queeny; Malone, Daniel C; Chong, Jenny W; Harris, Robin B; Labiner, David M.

In: Epilepsy Research, Vol. 139, 01.01.2018, p. 107-112.

Research output: Contribution to journalArticle

@article{c13d4796911646f7b7914b9099318bf1,
title = "An update on the prevalence and incidence of epilepsy among older adults",
abstract = "Objective To estimate the prevalence and incidence of epilepsy among beneficiaries of Arizona Medicare aged 65 and over. Methods An analysis of Medicare administrative claims data for 2009–2011 for the State of Arizona was conducted. Epilepsy was defined as a beneficiary who had either ≥ one claim with diagnostic code of 345.xx (epilepsy) or at least two claims with diagnosis code of 780.3x (seizure) ≥30 days apart. Stroke-related and psychiatric comorbidities were determined by diagnostic codes. Average annual prevalence and incidence were calculated and stratified by demographic characteristics and comorbidities. Odds ratios (OR) and 95{\%} confidence intervals (CI) were calculated as measures of effect for prevalence and incidence and the chi-square statistic was calculated to compare the proportions of epilepsy cases with and without comorbidities (alpha = 0.05). Results The overall average annual prevalence and incidence over the study period was 15.2/1000 and 6.1/1000, respectively. Relative to the 65–69 age group and White beneficiaries, the highest prevalence was observed for beneficiaries 85 years or older (19.8/1000, OR 1.66, 95{\%} CI 1.53–1.81) and Native Americans (21.2/1000, OR 1.42, 95{\%} CI 1.25–1.62). In contrast, the highest incidence rates were observed for beneficiaries 85 years and older (8.5/1000, OR 1.82, 95{\%} CI 1.60–2.07) and for Black beneficiaries (8.7/1000, OR 1.44, 95{\%} CI 1.12–1.86). The incidence rate for Native Americans was not significantly different from that for White beneficiaries (6.2/1000, OR 1.02, 95{\%} CI 0.81–1.29). More than one quarter of all cases (25.7{\%}) and 31{\%} of incident cases had either stroke-related and/or psychiatric comorbidities (all p-values < 0.001). Conclusions Epilepsy is a significant neurological disease among Medicare beneficiaries 65 years and older. Beneficiaries aged 85 and older and Black and Native Americans experienced higher rates of epilepsy than other demographic subgroups compared to White beneficiaries.",
keywords = "Comorbidities, Epilepsy, Incidence, Medicare, Prevalence",
author = "Queeny Ip and Malone, {Daniel C} and Chong, {Jenny W} and Harris, {Robin B} and Labiner, {David M}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.eplepsyres.2017.11.022",
language = "English (US)",
volume = "139",
pages = "107--112",
journal = "Epilepsy Research",
issn = "0920-1211",
publisher = "Elsevier",

}

TY - JOUR

T1 - An update on the prevalence and incidence of epilepsy among older adults

AU - Ip, Queeny

AU - Malone, Daniel C

AU - Chong, Jenny W

AU - Harris, Robin B

AU - Labiner, David M

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective To estimate the prevalence and incidence of epilepsy among beneficiaries of Arizona Medicare aged 65 and over. Methods An analysis of Medicare administrative claims data for 2009–2011 for the State of Arizona was conducted. Epilepsy was defined as a beneficiary who had either ≥ one claim with diagnostic code of 345.xx (epilepsy) or at least two claims with diagnosis code of 780.3x (seizure) ≥30 days apart. Stroke-related and psychiatric comorbidities were determined by diagnostic codes. Average annual prevalence and incidence were calculated and stratified by demographic characteristics and comorbidities. Odds ratios (OR) and 95% confidence intervals (CI) were calculated as measures of effect for prevalence and incidence and the chi-square statistic was calculated to compare the proportions of epilepsy cases with and without comorbidities (alpha = 0.05). Results The overall average annual prevalence and incidence over the study period was 15.2/1000 and 6.1/1000, respectively. Relative to the 65–69 age group and White beneficiaries, the highest prevalence was observed for beneficiaries 85 years or older (19.8/1000, OR 1.66, 95% CI 1.53–1.81) and Native Americans (21.2/1000, OR 1.42, 95% CI 1.25–1.62). In contrast, the highest incidence rates were observed for beneficiaries 85 years and older (8.5/1000, OR 1.82, 95% CI 1.60–2.07) and for Black beneficiaries (8.7/1000, OR 1.44, 95% CI 1.12–1.86). The incidence rate for Native Americans was not significantly different from that for White beneficiaries (6.2/1000, OR 1.02, 95% CI 0.81–1.29). More than one quarter of all cases (25.7%) and 31% of incident cases had either stroke-related and/or psychiatric comorbidities (all p-values < 0.001). Conclusions Epilepsy is a significant neurological disease among Medicare beneficiaries 65 years and older. Beneficiaries aged 85 and older and Black and Native Americans experienced higher rates of epilepsy than other demographic subgroups compared to White beneficiaries.

AB - Objective To estimate the prevalence and incidence of epilepsy among beneficiaries of Arizona Medicare aged 65 and over. Methods An analysis of Medicare administrative claims data for 2009–2011 for the State of Arizona was conducted. Epilepsy was defined as a beneficiary who had either ≥ one claim with diagnostic code of 345.xx (epilepsy) or at least two claims with diagnosis code of 780.3x (seizure) ≥30 days apart. Stroke-related and psychiatric comorbidities were determined by diagnostic codes. Average annual prevalence and incidence were calculated and stratified by demographic characteristics and comorbidities. Odds ratios (OR) and 95% confidence intervals (CI) were calculated as measures of effect for prevalence and incidence and the chi-square statistic was calculated to compare the proportions of epilepsy cases with and without comorbidities (alpha = 0.05). Results The overall average annual prevalence and incidence over the study period was 15.2/1000 and 6.1/1000, respectively. Relative to the 65–69 age group and White beneficiaries, the highest prevalence was observed for beneficiaries 85 years or older (19.8/1000, OR 1.66, 95% CI 1.53–1.81) and Native Americans (21.2/1000, OR 1.42, 95% CI 1.25–1.62). In contrast, the highest incidence rates were observed for beneficiaries 85 years and older (8.5/1000, OR 1.82, 95% CI 1.60–2.07) and for Black beneficiaries (8.7/1000, OR 1.44, 95% CI 1.12–1.86). The incidence rate for Native Americans was not significantly different from that for White beneficiaries (6.2/1000, OR 1.02, 95% CI 0.81–1.29). More than one quarter of all cases (25.7%) and 31% of incident cases had either stroke-related and/or psychiatric comorbidities (all p-values < 0.001). Conclusions Epilepsy is a significant neurological disease among Medicare beneficiaries 65 years and older. Beneficiaries aged 85 and older and Black and Native Americans experienced higher rates of epilepsy than other demographic subgroups compared to White beneficiaries.

KW - Comorbidities

KW - Epilepsy

KW - Incidence

KW - Medicare

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=85036642503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85036642503&partnerID=8YFLogxK

U2 - 10.1016/j.eplepsyres.2017.11.022

DO - 10.1016/j.eplepsyres.2017.11.022

M3 - Article

C2 - 29220741

AN - SCOPUS:85036642503

VL - 139

SP - 107

EP - 112

JO - Epilepsy Research

JF - Epilepsy Research

SN - 0920-1211

ER -